Recent News

• 08.25.2025 - Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on September 9
• 08.01.2025 - Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin’s Next Phase of Growth and Strategic Initiatives
• 05.28.2025 - Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on June 3
• 05.13.2025 - Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer’s Program Amid Encouraging Data
• 05.06.2025 - Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering
• 05.05.2025 - Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock

Recent Filings

• 08.07.2025 - 3 Initial statement of beneficial ownership of securities
• 08.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.04.2025 - EX-99.1 EX-99.1
• 08.04.2025 - 8-K Current report
• 07.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.21.2025 - 8-K Current report
• 07.17.2025 - 8-K Current report
• 06.17.2025 - DEF 14A Other definitive proxy statements
• 06.09.2025 - 8-K Current report
• 05.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]